Genetic insights into psychotic major depressive disorder: bridging the mood-psychotic disorder spectrum
- PMID: 39889373
- PMCID: PMC11830301
- DOI: 10.1016/j.ebiom.2025.105576
Genetic insights into psychotic major depressive disorder: bridging the mood-psychotic disorder spectrum
Abstract
Background: Psychotic major depressive disorder (MDD), a subtype of MDD characterised by psychotic symptoms that occur exclusively during mood episode, is clinically significant yet underexplored genetically due to its rarity. This study comprehensively examines the genetic basis of psychotic MDD and elucidates its position within the mood-psychotic spectrum.
Methods: This population-based cohort study used Swedish and Danish registry data for over 5.1 M individuals born between 1958 and 1993/1996. Specialist-diagnosed psychotic MDD was defined using ICD-10 sub-codes of MDD, F32.2/F32.3. We estimated familial aggregation/coaggregation using generalised estimating equations, heritability and genetic correlations using structural equation modelling. We also analysed ∼30,000 genotyped MDD cases from the UK Biobank and a Swedish cohort to explore which polygenic risk score (PRS) may predispose individuals to psychotic MDD.
Findings: With over 10,000 psychotic MDD identified from the two nationwide patient registers, this study highlights the familial aggregation of psychotic MDD, co-aggregation with mood and psychotic disorders, and its stronger genetic correlation with schizophrenia compared to non-psychotic MDD. The familial risks increased with closer biological relatedness, suggesting genetic influence. Pedigree-heritability of psychotic MDD was 30.17% (95% CI 23.53-36.80%). While the genetic correlation between psychotic and non-psychotic MDD was high (0.82, 95% CI 0.73-0.92), the psychotic subgroup showed a higher genetic correlation with schizophrenia than non-psychotic MDD (0.67 vs 0.46, p-value 7.55∗10-4). Within 30,000 genotyped MDD cases, individuals with psychotic MDD had higher mean PRS for schizophrenia and BD but a lower MDD PRS than non-psychotic MDD. PRS for BD type-I was associated with increased odds of psychotic MDD, while BD type-II PRS showed no significant association with psychotic MDD.
Interpretation: This study provides evidence for the genetic basis of psychotic MDD, underscoring its unique position bridging the spectrum of mood and psychotic disorders. These findings advance our understanding of the aetiology of psychotic MDD and contribute to the limited body of evidence on this phenotype by utilising large-scale population-based data.
Funding: European Research Council; US National Institutes of Mental Health; European Union Horizon 2020 Program; Swedish Research Council; Research Council of Norway; Swedish Foundation for Strategic Research; Hjärnfonden.
Keywords: Epidemiology; Genetic; Psychotic disorders; Psychotic major depressive disorder.
Copyright © 2025 The Author(s). Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of interests PFS was a paid advisor and shareholder for Neumora Therapeutics. ML has received lecture honoraria from Lundbeck pharmaceuticals outside the submitted work. OA is a consultant to Cortechs.ai and Precision-Health.AI and has received speaker’s honorarium from Otsuka, Lundbeck, Janssen and Sunovion. HL has received grants from Shire/Takeda, lecture honoraria from Shire/Takeda, Medici and Elovan, all outside the submitted work Coauthors declare no conflict of interest.
Figures
References
-
- Kendler K.S. Kraepelin and the differential diagnosis of dementia praecox and manic-depressive insanity. Compr Psychiatry. 1986;27(6):549–558. - PubMed
-
- Baryshnikov I., Sund R., Marttunen M., et al. Diagnostic conversion from unipolar depression to bipolar disorder, schizophrenia, or schizoaffective disorder: a nationwide prospective 15-year register study on 43 495 inpatients. Bipolar Disord. 2020;22(6):582–592. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
